arrow
S

Songjie Shen

chinese academy of medical sciences - peking union medical college
H指数:25
被引数:1,850

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rationale and Trial Design of DAWNA-FES Trial: Single-Arm Phase II Study of Endocrine Therapy With Dalpiciclib After Progression on CDK4/6 Inhibition Based on [18F]FES PET/CT in Patients With HR+/HER2-Advanced Breast Cancer

DAWNA-FES试验的合理性与试验设计:基于[18F]FES PET/CT的HR+/HER2-晚期乳腺癌患者在接受CDK4/6抑制剂治疗后进展时使用达比奇利布联合内分泌疗法的单臂II期研究

2026-04-300
OAAI
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide versus anthracycline plus docetaxel and cyclophosphamide regimen in women with high-risk, HER2-negative breast cancer: An open-label, randomized controlled trial

辅助卡培他滨联合多西他赛和环磷酰胺与蒽环类加多西他赛和环磷酰胺方案在高风险、HER2阴性乳腺癌患者中的比较:一项开放标签、随机对照试验

2025-06-090
OAAI
Breast cancer pre-clinical screening using infrared thermography and artificial intelligence: a prospective, multicentre, diagnostic accuracy cohort study
2023-09-042
OAAI